News
Professor Bredenoord wins prize for the most visible Utrecht scientist 2017
Prof. dr. Annelien Bredenoord, hoogleraar Ethiek van Biomedische Innovatie en verbonden aan de faculteit Geneeskunde en het Universitair Medisch Centrum Utrecht, heeft de Universiteit Utrecht Publiprijs 2017 gewonnen.
Johnson & Johnson Innovation Champions Leading Edge Science with 15 New Collaborations with Potential to Impact Patients’ Lives
Johnson & Johnson Innovation LLC today announced more than a dozen new collaborations to drive the development of novel solutions to impact healthcare. These collaborations bring the total number of strategic transactions executed by Johnson & Johnson Innovation to more than 350 since its establishment in 2012.
How can mathematics solve your challenge in life sciences?
Mathematics provides a surprising amount of techniques to solve challenges in the life sciences & health sector. Does your company have such challenges but no time to look into them? Or would you like to strengthen your contacts in the academic world? Sign up for the TU Eindhoven study group!
HUB Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
In a study published in Cell, Dr. Hans Clevers, CSO of HUB, has demonstrated that the heterogeneity of breast cancer subtypes can be captured using patient derived Organoid cultures. This new Organoid cancer model system can strongly support effective drug development and facilitates the link between clinical and laboratory data. This publication was also picked up by national newspaper De Volkskrant with the key message that this new system could help speed up drug development considerably while also saving money.
Top Sector Life Sciences & Health presents new Knowledge and Innovation Contract: Glow~Motion
De Topsector Life Sciences & Health (Health~Holland) publiceert het nieuwe Kennis- en Innovatiecontract 2018-2019, getiteld Glow~Motion. Dit Innovatiecontract vult de recentelijk gepresenteerde Kennis- en Innovatieagenda 2018-2021 Grow~Motion aan. Waar de agenda de ambities voor de komende vier jaar voor ‘Gezondheid en Zorg’ beschrijft, omvat het Innovatiecontract de implementatie en collectieve inzet op deze agenda.
Laser shoes prevent 'freezing' in Parkinson patients | Clear reduction in symptoms
Freezing of gait, an absence of forward progression of the feet despite the intention to walk, is a debilitating symptom of Parkinson's disease. Laser shoes that project a line on the floor to the rhythm of the footsteps help trigger the person to walk. The shoes benefit the wearer significantly, according to research by the University of Twente and Radboud university medical center, which will be published on December 20 in Neurology, the scientific journal of the American Academy of Neurology.
Health Value Creation raises €2 million for Innovative Surgical Devices
Health Value Creation BV, an innovative startup focusing on surgical devices for laparoscopic and bowel surgery, has raised €2 million in funding. The Series A round was led by Chemelot Ventures, assisted by co-investors Limburg Business Development Fund (LBDF) and existing shareholder Inkef Capital. The company will use the funding to obtain regulatory approval for two devices.More than 250 new medicines for children and rare diseases
Mede door EU-beleid zijn in tien jaar tijd 260 nieuwe medicijnen tegen zeldzame ziekten bij kinderen beschikbaar gekomen. Deze conclusie trekt de Europese Commissie in het rapport ‘10 jaar Verordening Geneesmiddelen voor pediatrisch gebruik’.
Science and industry collaborate on affordable alternatives for antibiotics
Bijna vijftig wetenschappers en twintig bedrijven gaan werken aan de ontwikkeling van nieuwe toegankelijke en betaalbare antibiotica, en alternatieven voor antibioticagebruik. Dat gebeurt in acht onderzoeksprojecten die groen licht hebben gekregen van NWO-domein Toegepaste en Technische Wetenschappen (TTW). NWO investeert samen met het ministerie van Volksgezondheid, Welzijn en Sport (VWS) bijna 7 miljoen euro in het onderzoeksprogramma.
Proteins may improve screening for colorectal cancer
While colorectal cancer screening already saves many thousands of lives, there is still room for improvement. By looking at a combination of specific proteins rather than at a single blood protein alone, substantially more patients with colorectal cancer and advanced adenomas could be detected. The study describing these findings, conducted by researchers from the Netherlands Cancer Institute and VU University Medical Center, is published in the Annals of Internal Medicine.